Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Nearly 9 In 10 Seniors Satisfied With Medigap
Medigap policyholders are overwhelmingly satisfied with their coverage and say it provides good value for their money, according to a new survey released today by the Blue Cross Blue Shield Association (BCBSA) and America"s Health Insurance Plans (AHIP).

FDA Approves Hologic's Less Invasive Permanent Contraception System
FDA has given final approval to Hologic"s Adiana permanent contraception system, the Boston Herald reports. The company hopes to market the procedure as an alternative to tubal ligation surgery for the roughly 700,000 U.S. women who undergo the procedure each year. Adiana is similar to Conceptus" Essure, which has been on the market since 2002.Adiana involves a two-step procedure that can be performed in about 15 minutes in a doctor"s office. The process consists of inserting a catheter into the fallopian tubes and delivering a low level of radio frequency energy to make a small lesion on the inside lining of each tube. The catheter then implants silicone polymer inserts, about the size of a grain of rice, on top of the lesions. The tubes become blocked as healthy cell tissue attaches to the inserts (McConville, Boston Herald, 7/9).
News of the day
Omega-3 Fatty Acids Appear To Impact AMD Progression
Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laboratory for Nutrition and Vision Research (LNVR), Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.
Sexual Health

Medimix International To Exhibit At American Society of Clinical Oncology AGM

Medimix International, a leader in global healthcare marketing research for life sciences industry, announced that it will be exhibiting at the 45th AGM of the American Society of Clinical Oncology, which will take place in Orlando, Florida from May 29-June 2, 2009. The annual ASCO meeting is considered to be the premier educational and scientific event in the oncology community, a forum for cutting-edge scientific and educational developments in oncology with a focus on personalizing cancer care. Medimix International has a long history of working in the field of oncology/hematology, one of its key therapeutic areas, and in fact around 35-40% of its yearly projects are conducted in that field. It currently manages a panel of more than 17,000 oncologists and over 13,000 hematologists from North America, Europe, Asia, Latin America, and the Middle East. Specialties included in the panel are medical, radiation, surgical, gynecology, and pediatric oncology, with Medimix"s demonstrating particular expertise in the areas of anemia, breast, lung, bowel, prostate, and renal cancers. "Oncology is a very challenging field where treatment options are continuously evolving," commented Dr. Tessa Schoor, Medimix"s Chief Medical Officer. "It is crucial for us to stay up to date on the new therapeutic outcomes that are discussed at the ASCO meeting every year. " With over 26,000 professionals from 128 countries attending the ASCO event, Medimix"s presence will have a dual purpose: to extend an invitation to these experts to become part of its new online community and to showcase its services to clients in the pharmaceutical, medical device and biotechnology fields. "Over 53% of visitors at ASCO come from outside the United States," noted Henry Gazay, CEO of Medimix International. "The reach of our onco/hematology panel being global, exhibiting at ASCO represents a unique opportunity to meet some of the key members of our community from diverse countries around the world. Physicians and KOLs will come to our booth to share their experience of working with us and working together. It is also a great opportunity to show new marketing services to our clients." Medimix International will be present at the ASCO exhibition, May 29- June 1, booth #426 Medimix International


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009